Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
I'm not a programmer, but I tried four vibe coding tools to see if I could build anything at all on my own. Here's what I did and did not accomplish.
Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback